Literature DB >> 19622510

Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire.

M Cirillo1, M Venturini, L Ciccarelli, F Coati, O Bortolami, G Verlato.   

Abstract

BACKGROUND: Monitoring adverse events during chemotherapy by clinicians is a standard practice but clinicians may report fewer side-effects or lower symptom severity than patients. Our aim was to compare symptoms self-reported by patients with symptoms registered by clinicians and nurses, to assess validity of a nurse reporting.
METHODS: From April to August 2007, a double-blind questionnaire with 13 common items graduated according to the National Cancer Institute's Common Terminology Criteria for Adverse Events was completed by clinicians and nurses for outpatients undergoing chemotherapy at our Medical Oncology Day Hospital Unit. Patients completed a modified questionnaire with simplified terms. They were requested to specify seriousness of symptoms with a subjective scale varying from 1 to 4. Every patient-nurse-clinician questionnaire was registered for the statistical analysis. Agreement was evaluated by Cohen's kappa coefficient.
RESULTS: Eighty-five paired questionnaires were completed. Patients, nurses and clinicians agreed on most symptoms and toxicity grade. Agreements between patients and nurses were stronger than those between patients and physicians for the six most common symptoms: asthenia (kappa 75% versus 37%), constipation (83% versus 45%), neuropathy (82% versus 55%), mucositis (78% versus 46%) and diarrhoea (90% versus 77%). These differences mainly reflected differences in the proportion of positive agreement: nurses were more able to detect symptoms self-reported by patients than physicians. The only exception was nausea, as kappa coefficient was very good for both health professionals (91% versus 89%). When considering the different grade of toxicity by the weighted kappa coefficient, we scored again the highest agreement between patient and nurse, with weighted kappa ranging from 55% (asthenia) to 86% (diarrhoea), and the lowest agreement between patient and physician, with weighted kappa ranging from 32% (asthenia) to 74% (nausea). The agreement between physician and nurse slightly improved, with weighted kappa ranging from 41% (constipation) to 77% (nausea).
CONCLUSION: Our results support the validity of nurse toxicity reporting and that the nurse staff could be successfully employed in collecting toxicity data because of a greater ability to elicit information from patients than the medical staff.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622510     DOI: 10.1093/annonc/mdp287

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  55 in total

1.  Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.

Authors:  Elad Neeman; Gillian Gresham; Navasard Ovasapians; Andrew Hendifar; Richard Tuli; Robert Figlin; Arvind Shinde
Journal:  Oncologist       Date:  2019-06-21

2.  Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy.

Authors:  Daniel L Hertz; Kelley M Kidwell; Kiran Vangipuram; Feng Li; Manjunath P Pai; Monika Burness; Jennifer J Griggs; Anne F Schott; Catherine Van Poznak; Daniel F Hayes; Ellen M Lavoie Smith; N Lynn Henry
Journal:  Clin Cancer Res       Date:  2018-04-27       Impact factor: 12.531

3.  Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.

Authors:  Hai-Hong Ye; Jia-Zhou Ye; Zhi-Bo Xie; Yu-Chong Peng; Jie Chen; Liang Ma; Tao Bai; Jun-Ze Chen; Zhan Lu; Hong-Gui Qin; Bang-De Xiang; Le-Qun Li
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

4.  Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries.

Authors:  Nataporn Chaipichit; Janet Krska; Thongchai Pratipanawatr; Narumol Jarernsiripornkul
Journal:  Int J Clin Pharm       Date:  2015-01-29

5.  The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life.

Authors:  Chiara Baratelli; Carmela Giovanna Cleopatra Turco; Gaetano Lacidogna; Elisa Sperti; Francesca Vignani; Donatella Marino; Clizia Zichi; Emmanuele De Luca; Marco Audisio; Daniela Ballaminut; Annalisa Bellezza; Paola Chiotto; Giovanna Ciriolo; Rossella Comite; Fulvia Codegone; Santina Florio; Luisa Fusco; Laura Polimeno; Donatella Pozzi; Eliana Zilio; Sabrina Terzolo; Massimo Di Maio
Journal:  Support Care Cancer       Date:  2019-04-04       Impact factor: 3.603

6.  Unanticipated frequency and consequences of regimen-related diarrhea in patients being treated with radiation or chemoradiation regimens for cancers of the head and neck or lung.

Authors:  Stephen Sonis; Linda Elting; Dorothy Keefe; Hoang Nguyen; Steven Grunberg; Pamela Randolph-Jackson; Michael Brennan
Journal:  Support Care Cancer       Date:  2014-08-16       Impact factor: 3.603

7.  Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade.

Authors:  Aaron C Tan; J Matt McCrary; Susanna B Park; Terry Trinh; David Goldstein
Journal:  Support Care Cancer       Date:  2019-04-10       Impact factor: 3.603

Review 8.  Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.

Authors:  Ysabella Z A Van Sebille; Romany Stansborough; Hannah R Wardill; Emma Bateman; Rachel J Gibson; Dorothy M Keefe
Journal:  Curr Oncol Rep       Date:  2015-11       Impact factor: 5.075

9.  Building a self-measuring healthcare system with computable metrics, data fusion, and substitutable apps.

Authors:  Kenneth D Mandl; Joshua C Mandel
Journal:  BMJ Outcomes       Date:  2015-04

10.  Patient-Reported Outcomes vs. Clinician Symptom Reporting During Chemoradiation for Rectal Cancer.

Authors:  Libertad T Flores; Antonia V Bennett; Ethel B Law; Carla Hajj; Mindy P Griffith; Karyn A Goodman
Journal:  Gastrointest Cancer Res       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.